Skip to content

Clinical trials

Retinal Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20111
20161
20193
20201
20214
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting3
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laboratoires Thea3
ProQR Therapeutics3
Novartis Pharmaceuticals2
AbbVie1
Elisigen, Inc.1
Group Health Centre1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Michael Mauer, MD1
Opthea Limited1
Sunnybrook Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases20
Eye Diseases10
Vision Disorders8
Eye Abnormalities5
Eye Diseases, Hereditary5
Retinal Degeneration5
Diabetes Mellitus4
Macular Degeneration4
Wet Macular Degeneration4
Blindness3

Trials

Showing 51 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.